Immuneering Corp (IMRX) KPIs and segments

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30

$3.71+0.04 (+1.09%)

Close on Nov 13, 2026Market cap $240.27MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Immuneering's business

Coming soon

This tab will track the numbers specific to Immuneering's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?